Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sackner, M. A.
Right arrow Articles by Sackner, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sackner, M. A.
Right arrow Articles by Sackner, J. D.

Chest, Vol 99, 896-903, Copyright © 1991 by American College of Chest Physicians

ARTICLES

Thoracocardiography. Part 2: Noninvasive measurement of changes in stroke volume; comparisons to impedance cardiograph

MA Sackner, RA Hoffman, BP Krieger, M Shaukat, D Stroh and JD Sackner
Division of Pulmonary Disease, University of Miami School of Medicine, Mount Sinai Medical Center, Miami Beach.

The thoracocardiograph (TCG) displays cardiac oscillations transmitted to the external surface of the thorax through inductive plethysmographic transducers placed transversely around the thorax near or about the xiphoid process. Such signals, with the appearance of ventricular volume curves, were used to compute changes of stroke volume (SV) and cardiac output (CO) in normal subjects. Their values were compared with changes of SV and CO measured with the impedance cardiograph (IC). Increases of SV and CO were produced with subcutaneous terbutaline and there was excellent agreement between TCG and IC values, best from TCG transducers placed at the xiphoid process and 3 cm caudal to it, although TCG locations 6 cm caudad and 3 cm cephalad to the xiphoid were also satisfactory. Since the site 3 cm caudad to the xiphoid process is known to anatomically transect solely a segment of the left ventricle, it was designated the TCG-Reference location. Both TCG and IC derived SV were not altered during postural shifts about a horizontal axis. Neither TCG nor IC showed the expected large decreases of SV from supine posture to head-up tilt. With baseline TCG and IC measurements in 60 degrees head-up tilt. MAST suit application increased CO measured with TCG but not with IC. Neither TCG nor IC revealed alteration of CO with nasal CPAP up to 10 cm H2O despite a rise in functional residual capacity (FRC) level of 870 ml. This investigation indicates that TCG has promise as a near continuous, noninvasive monitor of SV and CO in normal subjects if postural axis is fixed and does not require highly trained personnel or labor- intensiveness for its operation.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American College of Chest Physicians.